A discovery by Dr. Andre Veillette's team could impact the treatment of autoimmune diseases


The scientific journal Immunity, from the Cell Press group, publishes online today, and will publish in its Aug. 27 print issue, the results of a study conducted by a team of researchers led by Dr. André Veillette, director of the molecular oncology research unit at the Institut de recherches cliniques de Montréal. Their scientific breakthrough could have an impact on the treatment of multiple sclerosis and other autoimmune diseases.


[ Terug naar het hoofdmenu ]